Contact Members' Area Join
  • Exploring prevalence, genomics, clinical outcome, psychosocial, financial and quality of life impact of antifungal resistant dermatophyte infections in Pakistan

    Project lead

    Kauser Jabeen – Aga Khan University, Karachi, Pakistan

    Co-applicants

    Matthew C Fisher – Imperial College London, United Kingdom

    Rumina Hasan – Aga Khan University, Pakistan

    Joveria Farooqi – Aga Khan University, Pakistan

    Najia Ghanchi – Aga Khan University, Pakistan

    Afia Zafar – Aga Khan University, Pakistan

    Saadia Tabassum – Aga Khan University, Pakistan

    Nadia Ali Zafar – Jinnah Hospital, Pakistan

    Geographical focus

    Pakistan

    Research theme

    Microbial Pathogenesis, Biomarkers and Diagnostics, Innovative platforms

    Organism/pathogen

    Dermatophytes

    Lay summary:

    Despite a huge global burden, emerging antifungal resistance, and significant impact on health, dermatophytosis is a neglected disease entity that is not included in the WHO fungal priority list. In Pakistan, a low- or middle-income country, antifungal-resistant dermatophyte infections, specifically Trichophyton indotineae, are emerging. However, the incidence and impact on clinical outcomes, quality of life, and the financial and psychosocial condition of patients is unknown. Fundamental insights into resistance mechanisms, virulence factors, and transmission dynamics of drug-resistant dermatophytes are urgently needed. This multicentre project based in Pakistan aims to explore the epidemiology of antifungal resistance in recalcitrant dermatophyte infections and their psychosocial, financial, and clinical impact on patients. While the main focus of the project will be characterisation of strains obtained through clinical microbiology laboratories in Pakistan, whole genome sequencing will be performed for in-depth analysis of mechanisms of resistance, and transmission of antifungal-resistant dermatophytes. The results of this study will expand the overall knowledgebase around dermatophyte infections and can be used by multiple stakeholders towards the development of better surveillance, diagnostics, therapeutics, infection prevention, guidelines, and policy guidance.